Fructose Metabolism and Disease Mechanisms: From Nutritional Excess to Obesity and Multiorgan Pathophysiology
Frontiers in Bioscience-Elite · 2026-03-17 · 18 (1)
DOI: 10.31083/fbe46304 ↗At a glance
Übersichtsarbeit in Frontiers in Bioscience-Elite, published online on 2026-03-17. Written by Evelyn Sharon Sukumaran and 5 co-authors. Institution: Department of Pharmacology, Faculty of Pharmacy, Dr. M.G.R. Educational and Research Institute, 600017 Chennai, Tamil Nadu, India. Major MEDLINE topics: Obesity, Fructose. Cited 1 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Excessive fructose consumption has emerged as a critical driver of obesity and metabolic dysfunction, with far-reaching implications for multiple organ systems. This review synthesizes current evidence on the biochemical and molecular pathways underlying fructose induced disease mechanisms, discussing how fructose metabolism activates the “survival switch”, promotes fat storage, and generates uric acid, mitochondrial dysfunction, and oxidative stress, thereby disrupting energy homeostasis. Key organ-specific consequences are explored, including hepatic steatosis and progression to non-alcoholic fatty liver disease, pancreatic β-cell dysfunction, renal fibrosis, intestinal barrier disruption with microbial dysbiosis, cardiometabolic impairment, pulmonary inflammation, and neurocognitive decline with relevance to Alzheimer’s disease. Moreover, mechanistic insights highlight the role of fructokinase C activation, adenosine triphosphate (ATP) depletion, leptin resistance, pro-inflammatory signaling (mechanistic target of rapamycin complex-1 (mTORC1), renin angiotensin system (RAS), Toll-like receptor 4 (TLR4)), and cross-talk between fructose metabolism and organ-specific pathophysiology. Animal and human studies consistently reinforce the central role of fructose overload in driving obesity and associated complications. Meanwhile, this review frames fructose not merely as a caloric contributor but as a metabolic disruptor, thereby underscoring the urgent need for public health interventions, dietary regulation, and mechanistic research to mitigate fructose-driven metabolic disease.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacology, Faculty of Pharmacy, Dr. M.G.R. Educational and Research Institute, 600017 Chennai, Tamil Nadu, India.
- Pharmaco-Netinformatics Research Lab, Department of Psychiatry, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, 602105 Chennai, Tamil Nadu, Indi…
- Department of Community Medicine, Sree Balaji Medical College and Hospital, 600044 Chennai, Tamil Nadu, India.
- Department of Community Medicine, Vinayaka Mission Medical College and Hospital, 609609 Karaikal, Pondicherry, India.
- Department of Genetic Engineering, School of Bioengineering, College of Engineering and Technology SRM Institute of Science and Technology, 603203 Kattankulathur, Tamil Nadu, India.
Cite
APA
Sukumaran, E. S., Ganamurali, N., Pm, A., Raja, A., Narasimha, M. K., & Sabarathinam, S. (2026). Fructose Metabolism and Disease Mechanisms: From Nutritional Excess to Obesity and Multiorgan Pathophysiology. Frontiers in Bioscience-Elite, 18(1). https://doi.org/10.31083/fbe46304
Vancouver
Sukumaran ES, Ganamurali N, Pm A, Raja A, Narasimha MK, Sabarathinam S. Fructose Metabolism and Disease Mechanisms: From Nutritional Excess to Obesity and Multiorgan Pathophysiology. Frontiers in Bioscience-Elite. 2026;18(1). doi:10.31083/fbe46304
BibTeX
@article{Sukumaran2026,
author = {Sukumaran, Evelyn Sharon and Ganamurali, Nila and Pm, Aishwarya and Raja, Arun and Narasimha, Manoj Kumar and Sabarathinam, Sarvesh},
title = {Fructose Metabolism and Disease Mechanisms: From Nutritional Excess to Obesity and Multiorgan Pathophysiology},
journal = {Frontiers in Bioscience-Elite},
year = {2026},
volume = {18},
number = {1},
doi = {10.31083/fbe46304}
}
EUVIMED